3/5
01:50 pm
eras
Tango rises after Q4 results, clinical pact with Erasca [Seeking Alpha]
Low
Report
Tango rises after Q4 results, clinical pact with Erasca [Seeking Alpha]
3/5
07:41 am
eras
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
Low
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
3/5
07:13 am
eras
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat [Yahoo! Finance]
Low
Report
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat [Yahoo! Finance]
3/5
07:01 am
eras
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
Low
Report
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
3/2
04:22 pm
eras
Assessing Erasca (ERAS) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Erasca (ERAS) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
2/28
07:02 pm
eras
Erasca Conference: ERAS Teases 2026 Catalysts for Pan-RAS ERAS-0015 and Pan-KRAS ERAS-4001 [Yahoo! Finance]
Medium
Report
Erasca Conference: ERAS Teases 2026 Catalysts for Pan-RAS ERAS-0015 and Pan-KRAS ERAS-4001 [Yahoo! Finance]
2/28
03:22 pm
eras
Erasca, Inc. (ERAS): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Erasca, Inc. (ERAS): A Bull Case Theory [Yahoo! Finance]
2/24
08:00 am
eras
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
Medium
Report
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
2/5
08:15 am
eras
Erasca to Present at Upcoming Conferences in February [Yahoo! Finance]
Medium
Report
Erasca to Present at Upcoming Conferences in February [Yahoo! Finance]
2/5
08:00 am
eras
Erasca to Present at Upcoming Conferences in February
Medium
Report
Erasca to Present at Upcoming Conferences in February
2/3
09:49 am
eras
Erasca (ERAS) Is Up 10.4% After $225M Follow-On Offering And RAS Pipeline Updates - Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
Erasca (ERAS) Is Up 10.4% After $225M Follow-On Offering And RAS Pipeline Updates - Has The Bull Case Changed? [Yahoo! Finance]
2/2
04:29 am
eras
Mizuho Initiates Erasca (ERAS) With ‘Outperform' Rating and $16 PT [Yahoo! Finance]
Low
Report
Mizuho Initiates Erasca (ERAS) With ‘Outperform' Rating and $16 PT [Yahoo! Finance]
1/27
10:59 am
eras
Erasca (NASDAQ:ERAS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $16.00 price target on the stock.
Medium
Report
Erasca (NASDAQ:ERAS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $16.00 price target on the stock.
1/27
08:04 am
eras
Erasca (NASDAQ:ERAS) had its "buy" rating reaffirmed by analysts at Guggenheim.
High
Report
Erasca (NASDAQ:ERAS) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/26
08:04 am
eras
Erasca (NASDAQ:ERAS) had its price target raised by analysts at HC Wainwright from $11.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Erasca (NASDAQ:ERAS) had its price target raised by analysts at HC Wainwright from $11.00 to $15.00. They now have a "buy" rating on the stock.
1/26
08:03 am
eras
Erasca (NASDAQ:ERAS) was given a new $10.00 price target on by analysts at Morgan Stanley.
Low
Report
Erasca (NASDAQ:ERAS) was given a new $10.00 price target on by analysts at Morgan Stanley.
1/23
04:01 pm
eras
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Low
Report
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
1/22
01:21 am
eras
Erasca prices $225M stock offering at $10 per share [Seeking Alpha]
Medium
Report
Erasca prices $225M stock offering at $10 per share [Seeking Alpha]
1/21
08:54 pm
eras
Erasca Announces Pricing of Upsized Public Offering of Common Stock
Medium
Report
Erasca Announces Pricing of Upsized Public Offering of Common Stock
1/20
04:01 pm
eras
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
Low
Report
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
1/16
11:51 am
eras
Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike [Yahoo! Finance]
Neutral
Report
Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike [Yahoo! Finance]
1/16
08:03 am
eras
Erasca (NASDAQ:ERAS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Erasca (NASDAQ:ERAS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/15
04:41 pm
eras
Assessing Erasca (ERAS) Valuation After Encouraging Early ERAS-0015 Data At JP Morgan Conference [Yahoo! Finance]
Low
Report
Assessing Erasca (ERAS) Valuation After Encouraging Early ERAS-0015 Data At JP Morgan Conference [Yahoo! Finance]
1/15
03:27 pm
eras
Erasca (ERAS) Climbs to 3-Year High as Analyst Hikes PT by 83% [Yahoo! Finance]
Low
Report
Erasca (ERAS) Climbs to 3-Year High as Analyst Hikes PT by 83% [Yahoo! Finance]
1/15
08:31 am
eras
Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions [Yahoo! Finance]
High
Report
Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions [Yahoo! Finance]